MECHANISMS AND THERAPEUTIC TARGETING OF NSD2 IN ADVANCED PROSTATE CANCER

$411,702FY2018Defense Health AgencyDOD

Fundacio Institut D Investigacio Biomedica De Bellvitge Idibell

Investigators